Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion

肝细胞癌 医学 内科学 胃肠病学 阶段(地层学) 免疫组织化学 免疫染色 病理 生物 古生物学
作者
Nicolas Poté,François Cauchy,Miguel Albuquerque,Hélène Voitot,Jacques Belghiti,Laurent Castéra,Hervé Puy,Pierre Bédossa,Valérie Paradis
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:62 (4): 848-854 被引量:326
标识
DOI:10.1016/j.jhep.2014.11.005
摘要

Background & Aims Prothrombin induced by vitamin K absence-II (PIVKA-II) is a diagnostic and surveillance marker for HCC mainly used in Asia, and has also been shown to be a predictor of microvascular invasion (MVI), a major prognostic factor in HCC. However, experience with PIVKA-II in Europe remains limited. Methods In a French cohort, we conducted a case-control study to compare the performances of α-fetoprotein (AFP) and PIVKA-II serum levels for diagnosis of early stage HCC, and we determined the value of PIVKA-II serum and tissue expression in pre-operative detection of MVI. 43 cirrhotic control patients and 85 HCC cases were included, of which 54 (63.5%) had early stage HCC (n = 22 very early, n = 32 early). PIVKA-II tissue expression was assessed by immunohistochemistry in HCC surgical samples. Results For the diagnosis of early HCC, PIVKA-II had a sensitivity of 77% and a specificity of 82% at a cut-off of 42 mAU/ml, vs. 61% and 50% for AFP at a cut-off of 5.5 ng/ml (AUC 0.81 vs. 0.58, respectively). A PIVKA-II level >90 mAU/ml was an independent predictor of MVI (HR 3.5; 95% CI 1.08–11.8; p = 0.043). High PIVKA-II tissue expression was significantly associated with the presence of MVI (p = 0.001). When combining PIVKA-II immunostaining with the PIVKA-II serum level, sensitivity and specificity for the diagnosis of MVI increased from 70% to 87% and 63% to 90%, respectively. Conclusions PIVKA-II was more efficient than AFP for the diagnosis of early HCC, and could be used as a predictive biomarker of MVI. Prothrombin induced by vitamin K absence-II (PIVKA-II) is a diagnostic and surveillance marker for HCC mainly used in Asia, and has also been shown to be a predictor of microvascular invasion (MVI), a major prognostic factor in HCC. However, experience with PIVKA-II in Europe remains limited. In a French cohort, we conducted a case-control study to compare the performances of α-fetoprotein (AFP) and PIVKA-II serum levels for diagnosis of early stage HCC, and we determined the value of PIVKA-II serum and tissue expression in pre-operative detection of MVI. 43 cirrhotic control patients and 85 HCC cases were included, of which 54 (63.5%) had early stage HCC (n = 22 very early, n = 32 early). PIVKA-II tissue expression was assessed by immunohistochemistry in HCC surgical samples. For the diagnosis of early HCC, PIVKA-II had a sensitivity of 77% and a specificity of 82% at a cut-off of 42 mAU/ml, vs. 61% and 50% for AFP at a cut-off of 5.5 ng/ml (AUC 0.81 vs. 0.58, respectively). A PIVKA-II level >90 mAU/ml was an independent predictor of MVI (HR 3.5; 95% CI 1.08–11.8; p = 0.043). High PIVKA-II tissue expression was significantly associated with the presence of MVI (p = 0.001). When combining PIVKA-II immunostaining with the PIVKA-II serum level, sensitivity and specificity for the diagnosis of MVI increased from 70% to 87% and 63% to 90%, respectively. PIVKA-II was more efficient than AFP for the diagnosis of early HCC, and could be used as a predictive biomarker of MVI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
张伟发布了新的文献求助10
3秒前
3秒前
vivi完成签到,获得积分10
3秒前
3秒前
123完成签到,获得积分10
4秒前
syvshc的应助被wqf采纳,获得10
4秒前
冷静秀完成签到 ,获得积分10
5秒前
terryok完成签到,获得积分10
5秒前
苹果寻桃完成签到,获得积分10
5秒前
lx的应助被Aurora采纳,获得10
6秒前
bingrui发布了新的文献求助10
7秒前
7秒前
不吃茄子完成签到 ,获得积分10
7秒前
不圆月发布了新的文献求助10
7秒前
8秒前
七七发布了新的文献求助10
8秒前
hz发布了新的文献求助10
9秒前
晚峰完成签到,获得积分10
10秒前
miaofajin完成签到,获得积分10
10秒前
难过台灯完成签到,获得积分10
11秒前
海盗船长完成签到,获得积分10
11秒前
tnt完成签到,获得积分20
11秒前
诶诶完成签到,获得积分10
11秒前
科研通AI6.2的应助被祥云齐天采纳,获得30
11秒前
暖暖完成签到,获得积分10
12秒前
七七完成签到,获得积分10
13秒前
13秒前
超级故事发布了新的文献求助10
13秒前
UNIQUE发布了新的文献求助10
14秒前
鹿饮溪给鹿饮溪的求助进行了留言
14秒前
李健的小迷弟的应助被天天采纳,获得10
15秒前
JamesPei的应助被天天采纳,获得10
15秒前
赘婿的应助被天天采纳,获得10
15秒前
JamesPei的应助被天天采纳,获得10
15秒前
Lucas的应助被天天采纳,获得10
15秒前
orixero的应助被天天采纳,获得10
15秒前
15秒前
今后的应助被天天采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191353
求助须知:如何正确求助?哪些是违规求助? 9578210
关于积分的说明 21857444
捐赠科研通 7790659
什么是DOI,文献DOI怎么找? 3436607
关于科研通互助平台的介绍 2560359
邀请新用户注册赠送积分活动 2483315